Parker H Stewart - Apr 27, 2021 Form 4/A - Amendment Insider Report for IMPEL NEUROPHARMA INC (IMPL)

Role: Director
Signature: /s/ John Leaman, M.D. as attorney-in-fact
Stock symbol: IMPL
Transactions as of: Apr 27, 2021
Transactions value $: $0
Form type: 4/A - Amendment
Date filed: 6/22/2021, 05:47 PM
Date Of Original Report: Apr 29, 2021
Previous filing: Jun 22, 2021
Next filing: Jul 13, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	IMPL	Common Stock						20.2K	Apr 27, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the amount of securities beneficially owned by the reporting person following all transactions reported in Table I on the Form 4 filed on April 29, 2021.

Remarks:

The Form 4 filed on April 29, 2021 inadvertently reported the net exercise of Class A-2 preferred stock warrants and Class C-1 preferred stock warrants. The referenced warrants were cash exercised and therefore this amended Form 4 removes the effect of the withholding transactions as reported on the Form 4 by correcting the number of derivative securities beneficially owned by the reporting person following all reported transactions on Table I.